71573442
:
I have a different opinion from you. Those indicators are all short-term influencing factors. If we extend the time a little bit, they won't be a problem at all.
As the U.S. presidential election approaches in just two months, focus intensifies on the crucial debate between Vice President Kamala Harris and former President Donald Trump, scheduled for 9 p.m. ET on Tuesday, September 10. For investors strategizing around the "Trump trade" or the "Harris trade," the market's forward-looking reaction to their governing policies is critical. The election outcome will shape expectations of their administra...
SeanDiamond13
:
I don’t care if you HATE D T but you’d have to have the intellect of a 3 year old if you believe the USSR is better off w Communalla as leader. Hasn’t everyone had enough already?
Since 1928, the$S&P 500 Index (.SPX.US)$has averaged a 1.1% decline in September. This year, with an election looming and the prospect of a rate-cutting cycle, investor sentiment is more nervous. The "September effect" appears to be resurfacing, with the S&P 500 down 3.14% month-to-date as of Monday's close, now in the second week of September. Last week, we published "Wall Street is Bracing for September Curse Again. What's New and How to Tackle It," outlini...
Wall Street's three major indexes gained more than 1% on Monday as investors looked for bargains after the previous week's sell-off while they also waited for inflation reports in coming days and the Federal Reserve's next policy decision next week. Market Snapshot The Dow Jones Industrial Average rose 484.18 points, or 1.20%, to 40,829.59, the S&P 500 gained 62.63 points, or 1.16%, to 5,471.05 and the...
The market advanced on Monday, following a tough start to September, the last month of Q3. Just past 4 pm ET the$S&P 500 Index (.SPX.US)$traded up 1.16% the$Dow Jones Industrial Average (.DJI.US)$climbed 1.20%, and the$Nasdaq Composite Index (.IXIC.US)$climbed 1.16%. MACRO This week in macro, investors are waiting for slimmer pickings during the blackout period for Fed press commentary. FOMC members are barre...
32
3
8
Report
affable Blobfish_403
:
The intense struggle between political power and market power in the election, the outcome is uncertain, today's debate is a major highlight.
$Vir Biotechnology (VIR.US)$$Sanofi (SNY.US)$Reuters· 4 mins ago Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
literally. will it ever go down ?
More volatility can be expected with two key economic reports coming up - Aug CPI price on Wednesday, and PPI on Thursday.
$Invesco QQQ Trust (QQQ.US)$ $S&P 500 Index (.SPX.US)$ $Apple (AAPL.US)$ $Palantir (PLTR.US)$ $Johnson & Johnson (JNJ.US)$ $Coca-Cola (KO.US)$ $FuboTV (FUBO.US)$ $PepsiCo (PEP.US)$ $XPeng (XPEV.US)$ $Nike (NKE.US)$ $Yum! Brands (YUM.US)$ $Bank of America (BAC.US)$ $JPMorgan (JPM.US)$ $Financial Select Sector SPDR Fund (XLF.US)$
The "September effect" appears to be resurfacing, with the S&P 500 down 3.14% month-to-date as of Monday's close, now in the second week of September.
Last week, we published "Wall Street is Bracing for September Curse Again. What's New and How to Tackle It," outlini...
👀 stay tuned for updates on meeting outcomes
See 👇 for further info.
🚨 This Week’s AdCom:
$Iterum Therapeutics (ITRM.US)$ : Meeting ongoing 🤔
⇨ Sulopenem
‣ uUTI (Uncomplicated Urinary Tract Infection)
‣ AdCom: 9/9/24
🚨 Last Week’s PDUFAs:
$Travere Therapeutic (TVTX.US)$ : Approved 9/5 🎉
⇨ FILSPARI (Sparsentan)
‣ IgA nephropathy (IgAN)
‣ PDUFA: 9/5/24
$Avadel Pharmaceuticals (AVDL.US)$ : Awaiting decision 🤔
⇨ LUMRYZ (sodium oxybate)
‣...
Market Snapshot
The Dow Jones Industrial Average rose 484.18 points, or 1.20%, to 40,829.59, the S&P 500 gained 62.63 points, or 1.16%, to 5,471.05 and the...
nice, I didnt jinx it this time.
I still have a few shares to sell…
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded up 1.16% the $Dow Jones Industrial Average (.DJI.US)$ climbed 1.20%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 1.16%.
MACRO
This week in macro, investors are waiting for slimmer pickings during the blackout period for Fed press commentary. FOMC members are barre...
Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
No comment yet